Home›Insulin Human›Insulin Human + Exenatide

Does Insulin Human Interact with Exenatide?

Insulin Human and Exenatide have a major drug interaction according to U.S. FDA drug labeling data. Exenatide promotes insulin release, increasing hypoglycemia risk when combined with insulin secretagogues. Dose reduction of secretagogue or insulin recommended. The mechanism involves exenatide promotes insulin release from pancreatic beta-cells in the presence of elevated glucose concentrations. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Insulin Human Class
Insulin
Exenatide Class
GLP-1 Receptor Agonist
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Insulin Human and Exenatide occurs because exenatide promotes insulin release from pancreatic beta-cells in the presence of elevated glucose concentrations. Clinically, this means exenatide promotes insulin release, increasing hypoglycemia risk when combined with insulin secretagogues. dose reduction of secretagogue or insulin recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Insulin Human and your doctor is considering prescribing Exenatide (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Insulin Human(Myxredlin)+💊 Exenatide(Byetta)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Insulin
Drug B class
GLP-1 Receptor Agonist
Source
NLP:exenatide

What this means in plain English

Exenatide promotes insulin release, increasing hypoglycemia risk when combined with insulin secretagogues. Dose reduction of secretagogue or insulin recommended.

What the FDA label says

"Exenatide promotes insulin release from pancreatic beta-cells in the presence of elevated glucose concentrations"

📖 Source: NLP:exenatide

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Insulin Human and Exenatide against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.